4-Methylpiperazine-1-carbothioamide

Catalog No.: 
ACAQJU597
CAS No.: 
33860-28-5
Molecular Formula: 
C6H13N3S
Molecular Weight: 
159.26
4-Methylpiperazine-1-carbothioamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$175.00InquiryInquiry
1g95%$397.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Methylpiperazine-1-carbothioamide
IUPAC Name4-methylpiperazine-1-carbothioamide
MDL No.MFCD04116805
Molecular FormulaC6H13N3S
Molecular Weight159.26
SMILESS=C(N1CCN(C)CC1)N
InChI KeyQFACSDPLAUCZBD-UHFFFAOYSA-N
Synonym4-methylpiperazine-1-carbothioamide(SALTDATA: FREE);4-Methyl-1-piperazinyl-thiocarboxaMide;4-methyl-1-Piperazinecarbothioamide;1-Piperazinecarbothioamide, 4-methyl-;1-Thiocarbamoyl-4-methylpiperazine
CAS No.33860-28-5
PubChem CID2113086

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H302-H315-H318-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P310-P330-P332+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACAQJU597 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJACD865 route compound structure diagram
    ACJACD86534352-59-5In Stock
  2. Then
  3. ACAQJU597 route product structure diagram
    ACAQJU59733860-28-5
Inquiry

2. ACAQJU597 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJACD865 route compound structure diagram
    ACJACD86534352-59-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAQJU597 route product structure diagram
    ACAQJU59733860-28-5
Inquiry

3. ACAQJU597 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAQJU597 route product structure diagram
    ACAQJU59733860-28-5
Inquiry

Comments (0)